Mandatory notification of trade
(Thomson Reuters ONE) -
12 August 2011, Lysaker, Norway: Primary insider, CEO in Pronova BioPharma ASA,
Morten Jurs, bought 12 August 15,000 shares in the company.
The shares were bought at an average share price of NOK 7.85. Total number of
shares held by Mr Jurs after the purchase is 40,000 in addition to the 459,375
shares held by Jurs AS, beneficially owned by Morten Jurs.
This information is subject of the disclosure requirements pursuant to section
5-12 of the Norwegian Securities Trading Act.
This announcement is distributed by Thomson Reuters on behalf of
Thomson Reuters clients. The owner of this announcement warrants that:
(i) the releases contained herein are protected by copyright and
other applicable laws; and
(ii) they are solely responsible for the content, accuracy and
originality of the information contained therein.
Source: Pronova BioPharma ASA via Thomson Reuters ONE
[HUG#1538154]
Unternehmensinformation / Kurzprofil:
Datum: 12.08.2011 - 10:43 Uhr
Sprache: Deutsch
News-ID 57216
Anzahl Zeichen: 1114
contact information:
Town:
Lysaker
Kategorie:
Business News
Diese Pressemitteilung wurde bisher 143 mal aufgerufen.
Die Pressemitteilung mit dem Titel:
"Mandatory notification of trade"
steht unter der journalistisch-redaktionellen Verantwortung von
Pronova BioPharma ASA (Nachricht senden)
Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).
